Bruker Corporation BRKR | NASDAQ
After Hours
Next Earnings: Jan 06, 2025
Company Overview:
10 Year Performance Metrics:
BRKR Dividend Payments, Yield & Share Price charts
Unlock All Reports & Research Dividend Stocks like a BOSS!
BRKR Dividend Safety: Payout & Dividend to Free Cash Flow Ratios.
Dividend payout ration is Dividend/EPS, and indicates if company can afford to pay dividends from net income that it earned in the quarter.
Since EPS can be played with using different "accounting gymnastics", a better measure of dividends safety is Dividend to Free Cash Flow (FCF) ratio.
FCF is how much cash the company has earned each quarter, after paying all expenses not related to earnings.
Lower Ratio indicates SAFER Dividend! Ratios consistently close to, or over 100% are usually unsustainable and often indicate a dividend cut might be coming soon.
BRKR Earnings, Revenue, Cash & Debt, Shares Outstaning:
Revenue, EPS, Net Income & Ebitda - Estimates VS Actual:
Ratios, Profit Margins & Return on Capital:
BRKR Dividends Info:
BRKR Dividend History: Dates, Payments & Yield list
Below is a schedule of all BRKR dividend payments, ex-dates, share price on the day of the payment as well as TTM & forward yield
| Ex-Date | Payment Date | Amount | TTM Yield | Forward Yield | Price on Ex-Date |
|---|---|---|---|---|---|
| 12/02/2024 | 12/16/2024 | $0.050 | 0.34% | 0.34% | $58.37 |
| 08/30/2024 | 09/16/2024 | $0.050 | 0.3% | 0.3% | $67.19 |
| 06/03/2024 | 06/17/2024 | $0.050 | 0.31% | 0.31% | $64.51 |
| 05/31/2024 | 06/17/2024 | $0.050 | 0.31% | 0.31% | $65.51 |
| 02/29/2024 | 03/15/2024 | $0.050 | 0.23% | 0.23% | $86.54 |
| 11/30/2023 | 12/15/2023 | $0.050 | 0.31% | 0.31% | $65.09 |
| 08/31/2023 | 09/15/2023 | $0.050 | 0.3% | 0.3% | $65.60 |
| 05/31/2023 | 06/16/2023 | $0.050 | 0.29% | 0.29% | $69.10 |
| 02/28/2023 | 03/17/2023 | $0.050 | 0.29% | 0.29% | $68.92 |
| 11/30/2022 | 12/16/2022 | $0.050 | 0.3% | 0.3% | $67.41 |
| 08/31/2022 | 09/16/2022 | $0.050 | 0.34% | 0.36% | $56.00 |
| 05/31/2022 | 06/17/2022 | $0.050 | 0.29% | 0.32% | $62.48 |
| 02/28/2022 | 03/18/2022 | $0.050 | 0.24% | 0.28% | $70.37 |
| 11/30/2021 | 12/17/2021 | $0.040 | 0.2% | 0.2% | $80.99 |
| 08/31/2021 | 09/17/2021 | $0.040 | 0.18% | 0.18% | $88.31 |
| 05/28/2021 | 06/18/2021 | $0.040 | 0.23% | 0.23% | $69.44 |
| 03/04/2021 | 03/19/2021 | $0.040 | 0.27% | 0.27% | $58.63 |
| 11/30/2020 | 12/18/2020 | $0.040 | 0.32% | 0.32% | $50.61 |
| 08/31/2020 | 09/18/2020 | $0.040 | 0.38% | 0.38% | $42.02 |
| 05/29/2020 | 06/19/2020 | $0.040 | 0.37% | 0.37% | $43.28 |
| 03/06/2020 | 03/20/2020 | $0.040 | 0.36% | 0.36% | $44.67 |
| 11/29/2019 | 12/20/2019 | $0.040 | 0.31% | 0.31% | $51.19 |
| 08/30/2019 | 09/20/2019 | $0.040 | 0.37% | 0.37% | $43.17 |
| 05/31/2019 | 06/21/2019 | $0.040 | 0.38% | 0.38% | $41.77 |
| 03/04/2019 | 03/22/2019 | $0.040 | 0.41% | 0.41% | $38.64 |
| 11/30/2018 | 12/21/2018 | $0.040 | 0.48% | 0.48% | $33.14 |
| 08/31/2018 | 09/21/2018 | $0.040 | 0.45% | 0.45% | $35.58 |
| 06/01/2018 | 06/22/2018 | $0.040 | 0.52% | 0.52% | $30.50 |
| 03/05/2018 | 03/23/2018 | $0.040 | 0.54% | 0.54% | $29.65 |
| 12/01/2017 | 12/22/2017 | $0.040 | 0.46% | 0.46% | $34.81 |
| 08/31/2017 | 09/22/2017 | $0.040 | 0.55% | 0.55% | $29.09 |
| 06/01/2017 | 06/23/2017 | $0.040 | 0.58% | 0.58% | $27.39 |
| 03/06/2017 | 03/24/2017 | $0.040 | 0.67% | 0.67% | $23.71 |
| 12/01/2016 | 12/23/2016 | $0.040 | 0.71% | 0.71% | $22.51 |
| 09/01/2016 | 09/23/2016 | $0.040 | 0.53% | 0.71% | $22.44 |
| 06/02/2016 | 06/24/2016 | $0.040 | 0.3% | 0.6% | $26.48 |
| 03/02/2016 | 03/24/2016 | $0.040 | 0.14% | 0.57% | $27.96 |
Get the best Dividend Stock Research Tools:
Projected Future Returns & Dividends for BRKR
Based on past 10-year performance, here are BRKR growth metrics:Using BRKR CAGR metrics, we can estimate, that your initial $10000 investment, over next 10 years ago, should grow with dividends being reinvested (DRIP) as follows:
Share price CAGR of +11.24%
Dividend CAGR of +2.26%
| BRKR | |
|---|---|
| Current Price | $57.00 |
| Start Shares | 175.44 |
| Start Value | $10,000 |
| After 10 years: | |
| Final Share Count | 179.83 |
| Dividends Payment | $0.06 |
| Annual Dividends | $45 |
| Yield on cost | 0.45% |
| Share Price | $148.71 |
| Total Dividends | $394 |
| Final Value | $26,742 |
NOTE: Above numbers are our estimate based on BRKR's Dividend and Price CAGR over past 10 years.
These numebrs should only be considered as "potential future returns"! These numbers assume DRIP (reinvesting dividends).
We cannot guarantee that your actual returns will meet these estimates.
Company Info
Bruker Corporation (BRKR) had its IPO on 2000-08-04, and is trader on NASDAQ stock exchange.
Bruker Corporation develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States and internationally. The company operates through three segments: Bruker Scientific Instruments (BSI) Life Science, BSI NANO, and Bruker Energy & Supercon Technologies. It offers life science tools, and single and multiple modality systems; life science mass spectrometry; MALDI Biotyper rapid pathogen identification platform and related test kits, DNA test strips, and fluorescence-based polymerase chain reaction technology; genotype and fluorotype molecular diagnostics kits; research, analytical, and process analysis instruments and solutions; SARS-CoV 2 testing for the diagnosis of COVID-19 infection; and Fluorotyper-SARS-CoV 2 plus kits. It also provides range of portable analytical and bioanalytical detection systems, and related products; X-ray instruments; analytical tools for electron microscopes, as well as handheld, portable, and mobile X-ray fluorescence spectrometry instruments; atomic force microscopy instrumentation; non-contact nanometer resolution solution topography; and automated X-ray metrology, automated AFM defect-detection, and photomask repair and cleaning equipment. In addition, the company offers advanced optical fluorescence microscopy instruments; products and services to support the multi-omics needs of researchers in translational research, drug, and biomarker discovery; superconducting materials, such as metallic low temperature superconductors; devices and complex tools based on metallic low temperature superconductors; and non-superconducting high technology tools, such as synchrotron and beamline instrumentation. Bruker Corporation has a collaboration with Newomics Inc. on a LC-MS platform for drug discovery. The company was incorporated in 1991 and is headquartered in Billerica, Massachusetts.
BRKR website: https://www.bruker.com
